Clinical Trials Directory

Trials / Completed

CompletedNCT03097809

SEEG Investigation of Mood Dysregulation in Epilepsy

SEEG Investigation of Mood Dysregulation in People With Epilepsy

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Using the novel analysis of stereo-electroencephalography (SEEG) recordings, this proposal will investigate the activity and connectivity of mood regulation circuits in subjects with suspected epileptic focus who have undergone SEEG electrode implantation for monitoring of seizure activity.

Detailed description

It is well known that epilepsy is associated with mood dysregulation including symptoms of labile mood, impulse control problems, anxiety, depression and increase in incidence of suicide. However, until present the neurobiological basis of mood dysregulation in epilepsy has not been clear and has been mostly attributed to a psychological reaction to the illness. This has severely limited our understanding of the impairments in mood regulation that people with epilepsy often experience and has also limited the development of effective treatment for ameliorating psychosocial dysfunction in people with epilepsy. The identification of these circuits will not only increase our understanding of mood-regulation in epilepsy but also possibly provide biomarkers with which the effectiveness of new treatments can be investigated. Developing better diagnostic measures and treatments for mood dysregulation will be highly beneficial to the quality of life of subjects suffering from epilepsy.

Conditions

Interventions

TypeNameDescription
OTHERSEEG RecordingsTo directly record brain activity from the frontal-limbic circuitry of subjects in the resting state and while they engage in behavioral tasks designed to assess emotional response to negative stimuli and different aspects of impulse control and emotional processing

Timeline

Start date
2017-02-27
Primary completion
2018-01-30
Completion
2020-07-01
First posted
2017-03-31
Last updated
2020-07-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03097809. Inclusion in this directory is not an endorsement.